Combined therapy for vernal shield ulcer

REFERENCES

• Bonini S, Bonini S, Lambiase A, Marchi S, Pasqualetti P, Zuccaro O, Rama P, Magrini L, Juhas T, Bucci MG. Vernal keratoconjunctivitis revisited: a case series of 195 patients with long‐term follow‐up, Ophthalmology 2000; 107: 1157–1163.
   PubMed Web of Science ®Google Scholar
• Barney NP. Vernal and atopic keratoconjunctivitis. In: Krachmer JH, Mannis MJ, Holland EJ, eds. Cornea and External Disease: Clinical Diagnosis and Management. vol. 2, St louis: Mosby‐Year Book, Inc, 1997. p 811–817.
   Google Scholar
• Iqbal A, Jan S, Babar TF, Khan MD. Corneal complications of vernal catarrh. J Coll Physicians Surg Pak 2003; 13: 394–397.
   PubMedGoogle Scholar
• Rahi AHS, Buckley R, Grierson I. Pathology of corneal plaque in vernal keratoconjunctivitis. In: O’connor GR, Chandler JW, eds. Advances in Immunology and Immunopathology of Eye, New York: Masson, 1985.
   Google Scholar
• Cameron JA. Shield ulcers and plaques of cornea in vernal keratoconjunctivitis. Ophthalmology 1995; 102: 985–993.
   PubMed Web of Science ®Google Scholar
• Tanaka M, Takano Y, Dogru M, Fukagawa K, Asano‐kato N, Tsubota K, Fujishima H. A comparative evaluation of the efficacy of intraoperative mitomycin C use after the excision of cobblestone‐like papillae in severe atopic and vernal keratoconjunctivitis. Cornea 2004; 23: 326–329.
   PubMed Web of Science ®Google Scholar
• Singh S, Pal V, Dhull CS. Supratarsal injection of corticosteroids in the treatment of refractory vernal keratoconjunctivitis. Indian J Ophthalmol 2002; 50: 160–161.
   Google Scholar
• Ozbek Z, Burakgazi AZ, Rapuano CJ. Rapid healing of vernal shield ulcer after surgical debridement: a case report. Cornea 2006; 25: 472–473.
   Web of Science ®Google Scholar
• Rouher N, Pilon F, Dalens H, Fauquert JL, Kemeny JL, Rigal D, Chiambaretta F. Implantation of preserved human amniotic membrane for the treatment of shield ulcers and persistent corneal epithelial defects in chronic allergic keratoconjunctivitis. J Fr Ophtalmol 2004; 7: 1091–1097.
   Google Scholar
• Belfair N, Monos T, Levy J, Mnitentag H, Lifshitz T. Removal of giant vernal papillae by CO2 laser. Can J Ophthalmol 2005; 40: 472–476.
   Web of Science ®Google Scholar
• Benezra D, Matamoros N, Cohen E. Treatment of severe vernal keratoconjunctivitis with cyclosporine A eye drops. Transplant Proc 1988; 20: 644–649.
   PubMed Web of Science ®Google Scholar
• Kilic A, Gurler B. Topical 2% cyclosporine A in preservative‐free artificial tears for the treatment of vernal keratoconjunctivitis. Can J Ophthalmol 2006; 41: 693–698.
   PubMed Web of Science ®Google Scholar
• Pucci N, Novembre E, Cianferoni A, Lombardi E, Bernardini R, Caputo R, Campa L, Vierucci A. Efficacy and safety of cyclosporine eyedrops in vernal keratoconjunctivitis. Ann Allergy Asthma Immunol 2002; 89: 298–303.
   PubMed Web of Science ®Google Scholar
• Avunduk AM, Avunduk MC, Erdol H, Kapicioglu Z, Akyol N. Cyclosporine effects on clinical findings and impression cytology specimens in severe vernal keratoconjunctivitis. Ophthalmologica 2001; 215: 290–293.
   PubMed Web of Science ®Google Scholar
• Cetinkaya A, Akova YA, Dursun D, Pelit A. Topical cyclosporine in the management of shield ulcers. Cornea 2004; 23: 194–200.
   PubMed Web of Science ®Google Scholar
• Spadavecchia L, Fanelli P, Tesse R, Brunetti L, Cardinale F, Bellizzi M, Rizzo G, Procoli U, Bellizzi G, Armenio L. Efficacy of 1.25% and 1% topical cyclosporine in the treatment of severe vernal keratoconjunctivitis in childhood. Pediatr Allergy Immunol 2006; 17: 527–532.
   PubMed Web of Science ®Google Scholar
• Daniell M, Constantinou M, Vu HT, Taylor HR. Randomized controlled trial of cyclosporine A in steroid dependent allergic conjunctivitis. Br J Ophthalmol 2006; 90: 461–464.
   PubMed Web of Science ®Google Scholar
• Fujishima H, Fukagawa K, Satake Y, Saito I, Shimazaki J, Takano Y, Tsubota K. Combined medical and surgical treatment of severe vernal ketatoconjunctivitis. Jpn J Ophthalmol 2000; 44: 511–515.
   PubMed Web of Science ®Google Scholar
• Akpek EK, Dart JK, Watson S, Christen W, Dursun D, Yoo S. A randomized trial of topical cyclosporine 0.05% in topical steroid‐resistant atopic keratoconjunctivitis. Ophthalmology 2004; 111: 476–482.
   PubMed Web of Science ®Google Scholar